Results     31-May-22
Announcements
Marksans Pharma consolidated net profit declines 62.70% in the March 2022 quarter
Sales rise 26.60% to Rs 418.04 crore
Net profit of Marksans Pharma declined 62.70% to Rs 29.65 crore in the quarter ended March 2022 as against Rs 79.50 crore during the previous quarter ended March 2021. Sales rose 26.60% to Rs 418.04 crore in the quarter ended March 2022 as against Rs 330.20 crore during the previous quarter ended March 2021.

For the full year,net profit declined 21.69% to Rs 186.81 crore in the year ended March 2022 as against Rs 238.54 crore during the previous year ended March 2021. Sales rose 8.33% to Rs 1490.84 crore in the year ended March 2022 as against Rs 1376.18 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales418.04330.20 27 1490.841376.18 8
OPM %15.2228.89 -17.3624.68 -
PBDT73.9698.56 -25 292.29338.32 -14
PBT52.6097.22 -46 247.51302.16 -18
NP29.6579.50 -63 186.81238.54 -22

Previous News
  Marksans Pharma hits 52 week high on receiving USFDA nod for pain relief tablets
 ( Hot Pursuit - 12-Jul-23   11:29 )
  Marksans Pharma consolidated net profit declines 62.70% in the March 2022 quarter
 ( Results - Announcements 31-May-22   14:42 )
  Marksans Pharma receives USFDA approval for Acetaminophen and Ibuprofen Tablets
 ( Corporate News - 12-Jul-23   11:32 )
  Marksans Pharma subsidiary recalls drugs for packaging issue
 ( Corporate News - 21-Jun-22   12:11 )
  Marksans Pharma to convene board meeting
 ( Corporate News - 02-Aug-22   10:50 )
  Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter
 ( Results - Announcements 06-Nov-20   15:36 )
  Marksans Pharma consolidated net profit rises 19.54% in the December 2019 quarter
 ( Results - Announcements 11-Feb-20   15:11 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 30-May-24   16:01 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 02-Jun-20   17:55 )
  Marksans Pharma AGM scheduled
 ( Corporate News - 04-Aug-23   11:09 )
  Marksans Pharma standalone net profit declines 39.67% in the December 2016 quarter
 ( Results - Announcements 06-Feb-17   17:17 )
Other Stories
  Atlas Cycles (Haryana) reports standalone net loss of Rs 0.46 crore in the June 2024 quarter
  06-Jul-24   07:32
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top